Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.43EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.43EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GY.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GY.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GY.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.4.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.4.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.4.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.107EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.107ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.107ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.107EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.107EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.107ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.39.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.39.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.39.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used